Potential solutions to the copayment dilemma

June 30, 2008

A general policy of copayments or top-ups, allowing patients to pay privately for drugs, would be counter to the principles of the NHS and grossly unfair to desperately sick people, say experts on BMJ.com today.

"Once a policy is introduced for one disease, where will the process stop? It could come in for equally unproved dementia drugs" and would be "disastrous", writes Cam Donaldson, Director of the Institute of Health and Society at Newcastle University in a Personal View. This would led to escalating costs and threaten the equity of healthcare delivery.

Professor Ilora Finlay and Professor Nigel Crisp, both independent members of the House of Lords suggest that one solution may be to produce a definitive list of drugs for which copayments would be permitted, recognising that the National Institute of Clinical Excellence (NICE) cannot always produce a quick or definitive response.

They point out that other health systems have experienced problems with copayments. For example, data published in 2004, showed that in the US, where there is widespread use of copayments, 40% of patients did not seek medical attention when they needed it because of the potential costs involved. In contrast to the UK, where the figure was just 9%, the lowest in the study.

In the UK, NICE was created to evaluate the evidence of drugs and treatments from clinical trials and decide on their use in the NHS. This takes time, and patients are increasing faced with the dilemma that despite evidence that a licensed drug has a benefit, it has not yet been appraised or funded by NICE, and if they purchase it privately, they will be excluded from NHS care.

But according to the Finlay and Crisp, in practice, the number of patients wanting to pay for additional drugs is small and most are drugs that have yet to be reviewed by NICE, or for which there is insufficient evidence of a benefit to patients.

They suggest accelerating the NICE process as much as possible and compiling a definitive list of drugs for which copayments would be sanctioned on the basis of four criteria:Patients who are unwilling or unable to participate in a clinical trial should be willing for their treatment and its outcomes to be recorded on a register to monitor adverse incidents and to be used in subsequent reviews by NICE.

A government review of whether patients should be able to remain NHS patients if they pay privately for drugs is due to report in October this year. This will not be an easy task, say the authors, it will have to tackle some difficult issues including whether copayments should cover the cost of administering drugs and any complications arising from private treatment as well as the cost of the drug itself.

Donaldson believes that to control healthcare costs and address the dilemmas posed by "budget-busting" cancer drugs, governments need to target the supply side of the market and not try to limit patient access by ineffective and unfair "user fees" that do nothing to increase access.

It is vital that patients and the public continue to be involved in making decisions about health and healthcare, says Donaldson. But, "If we want to raise money in a way that is consistent with what we want to achieve in health care, there is another way--it's called taxation", he concludes.
-end-
Contacts:
Professor Ilora Finlay, House of Lords, Westminster, London, UK
Tel: + 44 (0) 207 219 6693
Email: finlayi@parliament.uk

Professor Cam Donaldson, Director, Institute of Health and Society, Newcastle University, Newcastle, UK.
Tel: + 44 (0)191 222 5593 or +44 (0)191 222 3463 (PA, Anita Tibbs) or +44 (0)191 222 8761 (PA, Catherine Brennand)
Email: cam.donaldson@ncl.ac.uk

Click here to view personal view: http://press.psprings.co.uk/bmj/june/copaymentspv.doc
Click here to view editorial: http://press.psprings.co.uk/bmj/june/copaymentsed.doc

BMJ

Related Healthcare Articles from Brightsurf:

How to protect healthcare workers from COVID-19
Researchers are developing simple and inexpensive tools--like a DIY ventilator--to treat patients more effectively and prevent disease transmission in hospitals.

Healthcare as a climate solution
Although the link may not be obvious, healthcare and climate change -- two issues that pose major challenges around the world -- are in fact more connected than society may realize.

Healthcare's earthquake: Lessons from COVID-19
Leaders and clinician researchers from Beth Israel Lahey Health propose using complexity science to identify strategies that healthcare organizations can use to respond better to the ongoing pandemic and to anticipate future challenges to healthcare delivery.

Poor women in Bangladesh reluctant to use healthcare
A study, published in PLOS ONE, found that the women living in Dhaka slums were reluctant to use institutionalised maternal health care for fear of having to make undocumented payments, unfamiliar institutional processes, lack of social and family support, matters of honour and shame, a culture of silence and inadequate spousal communication on health issues.

Women and men executives have differing perceptions of healthcare workplaces according to a survey report in the Journal of Healthcare Management
Healthcare organizations that can attract and retain talented women executives have the advantage over their peers, finds a special report in the September/October issue of the Journal of Healthcare Management, an official publication of the American College of Healthcare Executives (ACHE).

Greater financial integration generally not associated with better healthcare quality
New findings from a Dartmouth-led study, published in the August issue of Health Affairs, show that larger, more integrated healthcare systems do not generally deliver better quality care, and that there is significant variation in quality scores across hospitals and physician practices, regardless of whether they are independent or owned by larger systems.

Wearable sensor may help to assess stress in healthcare workers
A wearable biosensor may help monitor stress experienced by healthcare professionals, according to a study published in Physiological Reports.

Healthcare innovators focus on 'quality as a business strategy' -- update from Journal of Healthcare Quality
Despite two decades of effort -- targeting care processes, outcomes, and most recently the value of care - progress has been slow in closing the gap between quality and cost in the US healthcare system.

How runaway healthcare costs are a threat to older adults and what to do about it
Empowering Medicare to directly negotiate drug prices, accelerating the adoption of value-based care, using philanthropy as a catalyst for reform and expanding senior-specific models of care are among recommendations for reducing healthcare costs published in a new special report and supplement to the Winter 2019-20 edition of Generations, the journal of the American Society of Aging (ASA).

How can healthcare achieve real technology driven transformation?
Real transformation in healthcare through the adoption of artificial intelligence (AI), robotics, telecommunications, and other advanced technologies could provide significant improvements in healthcare quality, productivity, and access.

Read More: Healthcare News and Healthcare Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.